STOCK TITAN

BFHIV Stock Price, News & Analysis

BFHIV
Published by Stock Titan Data refreshed

Company Description

For FY2025, BFHIV reported revenue of $3.8B with net income of $518.0M and diluted earnings per share of $10.89. The company operates at a net profit margin of 13.5%.

This page collects what Stock Titan holds for BFHIV, including price data, SEC filings, and financial highlights.

Stock Performance

—
-
-
-
Performance 1 year

BFHIV Metrics & Rankings

Latest News

No recent news available for BFHIV.

Financial Highlights

BFHIV generated $3.8B in revenue in FY2025, and net income was $518.0M, reflecting a 13.5% net profit margin. Diluted earnings per share stood at $10.89. The company generated $2.1B in operating cash flow.

$3.8B
Revenue (FY2025)
$518.0M
Net Income (FY2025)
$2.1B
Operating Cash Flow

Upcoming Events

No upcoming events scheduled for BFHIV.

Frequently Asked Questions

The FY2025 revenue of BFHIV (BFHIV) is $3.8B, from its most recent completed fiscal year.

The FY2025 net income of BFHIV (BFHIV) is $518.0M, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of BFHIV (BFHIV) is $10.89 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of BFHIV (BFHIV) is $2.1B for FY2025, its most recent completed fiscal year. Learn about cash flow.

The net profit margin of BFHIV (BFHIV) is 13.5% for FY2025, its most recent completed fiscal year. Learn about profit margins.